Does Cigna Cover ADHD Treatment in Florida? A 2026 Guide

Last updated: September 1, 2026

Cigna commercial plans in Florida may cover ADHD evaluation, follow-up, and some stimulant or non-stimulant medications when the visit is medically necessary, in network, and allowed on your medical policy and Express Scripts list. Coverage is not automatic. Federal MHPAEA and Fla. Stat. § 627.668 set a floor for many fully insured policies. Cigna PA Policy IP0477 (effective May 15, 2026 on many Cigna commercial lists) typically requires prior authorization for stimulants. Always verify your own benefits before you book.

See if you may qualify for online ADHD evaluation through Klarity’s network of 2,000+ licensed providers. You can also read about ADHD care or browse conditions we treat.

TLDR

• Cigna may cover medically necessary ADHD visits and some ADHD drugs in Florida. Benefits vary by employer PPO/HMO, Florida Marketplace, Medicare Advantage, and Medicaid managed care products.
• Federal MHPAEA plus Fla. Stat. § 627.668 (optional/make-available mental health coverage on many fully insured policies) apply to many commercial products. They do not rewrite self-funded ERISA plan documents or Medicare Advantage formularies. § 627.668 is not a stimulant guarantee.
• Florida Statutes § 456.47 governs telehealth practice. It does not force Cigna to pay every video visit. Coverage still depends on the plan.
• Pharmacy benefits typically run through Express Scripts (ESI). Stimulants (methylphenidate, amphetamine salts, lisdexamfetamine) often need prior authorization under PA Policy IP0477 (all stimulants PA on many Cigna lists as of May 15, 2026), plus quantity limits and generic-first steps. Do not confuse this with Carelon Rx (Anthem) or OptumRx (UnitedHealthcare).
• HHS/DEA telemedicine flexibilities for prescribing many controlled medications currently run through December 31, 2026. ADHD stimulants are Schedule II. Atomoxetine, viloxazine, and guanfacine ER are typically not Schedule II.
• CVS/Caremark Zepbound timing (July 1, 2025 removal / October 1, 2026 reinstatement on many lists) is an Aetna/Caremark obesity story. It does not control Express Scripts ADHD drugs. Cigna/ESI did not remove Zepbound the same way; that still does not decide ADHD coverage.
• Medicare GLP-1 Bridge ($50/month Wegovy/Zepbound/Foundayo via CMS) is a Medicare obesity program. It does not pay for ADHD stimulants on Cigna commercial plans.
• Verify benefits on myCigna and Express Scripts. For many fully insured Florida complaints, Florida DFS Division of Consumer Services / FLOIR consumer help is often 1-877-693-5236 (1-877-MY-FL-CFO). Medicare Advantage appeals follow CMS, then often Maximus IRE at 1-855-887-6668. AHCA/Medicaid products follow Florida Medicaid rules, not this commercial page. If you are in crisis, call or text 988.

Disclaimer: This article is educational. It is not a benefits determination, diagnosis, or guarantee of payment. Coverage varies by plan. Verify benefits with Cigna and your clinician before you book.

Does Cigna cover ADHD treatment in Florida?

Often, some of it, with caveats. Evaluation visits and medication management may process as medical benefits on many Cigna commercial plans when the visit is medically necessary and in network. Medication is a separate pharmacy question. Copays, deductibles, and whether Klarity is in network still sit in your Summary of Benefits and Coverage, medical policy, and Express Scripts drug list.

Self-funded ERISA employer plans follow federal rules and the plan document more than Fla. Stat. § 627.668. Medicare Advantage, Medicaid, and dual-eligible products follow CMS and Florida Medicaid rules, not § 627.668 in the same way. Always treat this page as education, not a coverage determination.

Do not mix Cigna with Florida Blue (Blue Cross and Blue Shield of Florida) or with Anthem. Related Florida guides: Anthem Florida ADHD, Anthem Florida anxiety, and Anthem Florida depression.

Check if your plan may cover an ADHD visit.

Parity in Florida: what § 627.668 does and does not do

Two layers matter in 2026:

1. Federal MHPAEA. Group health plans and many individual plans that cover mental health generally cannot apply more restrictive financial requirements or treatment limitations than they apply to medical/surgical care in the same classification.
2. Fla. Stat. § 627.668 addresses optional/make-available coverage for mental and nervous disorders on many fully insured policies written in Florida. It is a make-available mental health rule, not a mandate that every stimulant must sit on a preferred tier.

Parity does not mean every stimulant is preferred or that prior authorization is illegal. It means the plan generally cannot make ADHD care harder to use than comparable medical care in the same classification. If Cigna denies a brand stimulant after a generic alternative exists, that is often a formulary or IP0477 PA issue, not an automatic parity violation. If the denial is a blanket mental-health visit cap that medical visits do not face, parity may apply. Keep those buckets separate when you appeal.

Florida DFS consumer materials and complaint intake: myfloridacfo.com/division/consumers. Helpline: 1-877-693-5236.

Telehealth ADHD visits and controlled-substance rules

Florida Statutes § 456.47 governs how clinicians may practice telehealth in Florida. It does not rewrite Cigna’s medical policy or Express Scripts PA. Many fully insured plans still reimburse video visits that would be covered in person when clinically appropriate. Employer self-funded plans may still pay for telehealth, but Florida insurance statutes may not bind them.

Klarity providers licensed in Florida can evaluate ADHD by video when clinically appropriate. Same-day appointments are often available. Coverage still depends on network status and cost share.

Federal controlled-substance telemedicine rules remain a separate overlay. HHS and DEA have extended certain telemedicine flexibilities through December 31, 2026. Stimulants remain Schedule II. Your clinician still must follow DEA, Florida prescriber, EPCS, and plan rules. See DEA guidance. Florida Prescription Drug Monitoring Program review may apply before some controlled prescriptions.

How Express Scripts and IP0477 usually treat ADHD drugs

Check your 2026 list on myCigna and the Express Scripts member tools. Plans often:

• Require PA for methylphenidate, mixed amphetamine salts, lisdexamfetamine, and related stimulants under Cigna PA Policy IP0477 (all stimulants PA on many lists, effective May 15, 2026)
• Prefer certain generics before brand Concerta, Vyvanse, or Adderall XR
• Cover atomoxetine, guanfacine ER, clonidine ER, or bupropion on different tiers when medically necessary
• Apply quantity limits and documentation (age of diagnosis, rating scales, cardiac history, substance-use screening)

Klarity clinicians can help you understand what a PA packet often includes. They cannot promise Cigna will approve a drug. Do not confuse Express Scripts IP0477 with Carelon Rx (Anthem), OptumRx (UnitedHealthcare), CVS/Caremark (typical Aetna), or Humana Pharmacy Solutions (typical Medicare Advantage).

NIMH estimates lifetime ADHD prevalence in U.S. adults aged 18 to 44 at 8.1%. CDC estimates about 7 million (11.7%) U.S. children aged 3-17 have ever been diagnosed with ADHD. Those figures describe need. They do not decide your Cigna copay.

See if you may qualify for online ADHD care.

What an ADHD evaluation typically includes

A licensed clinician typically reviews history, current symptoms, function at work or school, other mental health conditions, cardiac and substance-use history, and whether a stimulant or non-stimulant is appropriate. Rating scales and collateral history often help. A prescription is not guaranteed. If a stimulant is clinically appropriate, the clinician still must meet DEA, Florida, and Cigna/ESI rules.

Klarity’s network includes 2,000+ licensed providers. Availability varies by Florida license and appointment inventory. Speed language on this page does not promise a same-day slot for every ZIP code.

Appeals, Medicare Advantage, and Medicaid

If Cigna or Express Scripts denies a visit or drug:

1. Read the denial and medical policy or IP0477 criteria.
2. Ask your clinician for a PA or exception packet with diagnosis, prior trials, and clinical notes.
3. Use Cigna’s internal appeal, then external review when the product allows it.
4. For many fully insured Florida commercial complaints, contact DFS/FLOIR at 1-877-693-5236.

Medicare Advantage follows CMS 42 CFR Part 422, not Fla. Stat. § 627.668. After plan reconsideration, Independent Review Entity review is often through Maximus at 1-855-887-6668. AHCA and Florida Medicaid managed care follow Medicaid rules. This page does not describe Medicaid coverage. Dual-eligible members should confirm which card pays first.

The Medicare GLP-1 Bridge is a CMS obesity drug program. It is not an ADHD benefit and does not replace IP0477.

Related Klarity guides

• Does Anthem cover ADHD treatment in Florida?
• Does Anthem cover anxiety treatment in Florida?
• Does Anthem cover depression treatment in Florida?
• Does Anthem cover weight loss treatment in Florida?
• ADHD condition overview

Verify your benefits and see if you may qualify for an online ADHD evaluation. Coverage varies by plan. If you are in crisis, call or text 988.